Search for Articles:
Journal:
Subject:
Article

China’s Role in the Global Governance of Synthetic Biology: Between Revisionism and the Status Quo


Xiaohui Xu1,*

School of International Relations & Public Affairs, Fudan University, Shanghai, China
Correspondence: Xiaohui Xu, E-mail: xhxu21@m.fudan.edu.cn
 
J. Int. Eco. Glo. Gov., 2025, 2(6), 37-51; https://doi.org/10.12414/jiegg.250841
Received : 24 Jul 2025 / Revised : 01 Sep 2025 / Accepted : 06 Sep 2025 / Published : 25 Sep 2025
© The Author(s). Published by MOSP. This is an open access article under the CC BY-NC license.
Cite
Abstract
 
As a rapidly evolving frontier technology, synthetic biology poses significant global governance challenges that remain underexplored in international relations. This study combines the institutional design framework of global governance with the status quo–revisionist lens from international political economy to assess China’s role in the global governance of synthetic biology. It finds that China introduced the Tianjin Biosecurity Guidelines as a soft-law instrument that complements the hard-law Biological Weapons Convention, enhancing scientific community engagement and fostering consensus in research and regulation. The study concludes that China adopts a bounded revisionist approach, advancing normative innovation within the framework of existing institutions rather than in opposition to them. More broadly, the Tianjin Biosecurity Guidelines demonstrate how states can employ soft law to supplement established yet incomplete global governance frameworks, strategically position themselves, and secure international support. This study thus offers new insights into the dynamic alignment of state strategies and institutional design in the global governance of emerging technologies.
 
Keywords: Global Governance, China, Bounded Revisionism, Synthetic Biology, Emerging Technologies
 
Download the full text PDF for viewing and using it according to the license of this paper.

Funding

This research was funded by National Key R&D Program of the Ministry of Science and Technology “Global Governance and International Cooperation in Synthetic Biology R&D and Application” (2020YFA0908604).

Conflicts of Interest:

    The authors declare that they have no conflicts of interest to report regarding the present study.

References

  1. Abbott, K. W., & Snidal, D. (2000). Hard and soft law in international governance. International Organization, 54(3), 421-456.
  2. Baumann, M. O., Haug, S., & Weinlich, S. (2024). From developing country to superpower? China, power shifts and the United Nations development pillar. Global Policy, 15, 51-61.
  3. Breslin, S. (2013). China and the global order: signalling threat or friendship? International Affairs, 89(3), 615-634.
  4. Driessen, M., & Zhu, R. (2024). Chinese standards from the ground up. China Information, 38(2), 135-156.
  5. Duggan, N., & Naarajärvi, T. (2015). China in global food security governance. Journal of Contemporary China, 24(95), 943-960.
  6. Fägersten, B., & Rühlig, T. (2019). China’s standard power and its geopolitical implications for Europe. Swedish Institute of International Affairs.
  7. Gamito, M. C. (2023). The influence of China in AI governance through standardisation. Telecommunications Policy, 47(10), 102673.
  8. Glaser, C. (2011). Will China's rise lead to war? Why realism does not mean pessimism. Foreign Affairs, 80-91.
  9. Gómez-Tatay, L., & Hernández-Andreu, J. M. (2019). Biosafety and biosecurity in synthetic biology: a review. Critical reviews in environmental science and technology, 49(17), 1587-1621.
  10. Gronvall, G. K., Wang, L., McGrath, P. F., Cicero, A. J., Yuan, Y., Parker, M. I., ... & Trotochaud, M. (2022). The biological weapons convention should endorse the Tianjin Biosecurity Guidelines for Codes of Conduct. Trends in microbiology, 30(12), 1119-1120.
  11. Hameiri, S., & Zeng, J. (2020). State transformation and China’s engagement in global governance: the case of nuclear technologies. The Pacific Review, 33(6), 900-930.
  12. Hongyi, L. (2021). The role and logic of nontraditional security in China’s engagement in global governance mechanisms under Xi Jinping’s Regime. Journal of Chinese Political Science, 26(3), 505-523.
  13. ​​​​​​​Hopewell, K. (2025). Challenging the status quo-revisionist power dichotomy: China and the United States in the trade regime. Review of International Political Economy, 1-23.
  14. Ikenberry, G. J. (2008). The rise of China and the future of the West-Can the liberal system survive. Foreign Affairs., 87, 23.
  15. Johnston, A. I. (2003). Is China a status quo power?. International Security, 27(4), 5-56.
  16. Kahler, M. (2013). Rising powers and global governance: negotiating change in a resilient status quo. International Affairs, 89(3), 711-729.
  17. Keiper, F., & Atanassova, A. (2020). Regulation of synthetic biology: developments under the convention on biological diversity and its protocols. Frontiers in bioengineering and biotechnology, 310.
  18. Koremenos, B., Lipson, C., & Snidal, D. (2001). The rational design of international institutions. International Organization, 55(4), 761-799.
  19. Lai, H. E., Canavan, C., Cameron, L., Moore, S., Danchenko, M., Kuiken, T., ... & Freemont, P. S. (2019). Synthetic biology and the United Nations. Trends in Biotechnology, 37(11), 1146-1151.
  20. Li, J., Zhao, H., Zheng, L., & An, W. (2021). Advances in synthetic biology and biosafety governance. Frontiers in bioengineering and biotechnology, 9, 598087.
  21. Luo, X. & Cheng, R. (2013). Regional and country distribution studies of international science and technology organizations. Science and Technology Management Research, 33(2), 237-241. (罗学优 & 程如烟. (2013). 国际科技组织的地区和国别分布研究. 科技管理研究, 33(2), 237-241.)
  22. Ministry of Foreign Affairs of the People’s Republic of China, Promoting Responsible Biological Research: Working Document on The Tianjin Biosecurity Guidelines for Codes of Conduct for Scientists,https://www.mfa.gov.cn/wjb_673085/zzjg_673183/jks_674633/zclc_674645/hwhsh_674653/202311/t20231115_11180648.shtml(中华人民共和国外交部,关于倡导负责任的生物科研:《科学家生物安全行为准则天津指南》的工作文件)。
  23. Namdeo, S. K., & Zhang, J. Y. (2024). Rethinking science diplomacy and global biosecurity: challenges, emerging practices and the way forward. International Affairs, 100(6), 2623-2635.
  24. Novossiolova, T., Bakanidze, L., & Perkins, D. (2019). Effective and comprehensive governance of biological risks: A network of networks approach for sustainable capacity building. In Synthetic biology 2020: Frontiers in risk analysis and governance (pp. 313-349). Cham: Springer International Publishing.
  25. Paradise, J. F. (2019). China’s quest for global economic governance reform. Journal of Chinese Political Science, 24(3), 471-493.
  26. Peng, Y. (2020). The Era of Synthetic Biology: Biosecurity, Biosecurity and Governance. Journal of International Security Studies, 38(5), 29-57. (彭耀进. (2020). 合成生物学时代:生物安全、生物安保与治理. 国际安全研究, 38(5), 29-57.)
  27. Qian, J., Vreeland, J. R., & Zhao, J. (2023). The impact of China's AIIB on the World Bank. International Organization, 77(1), 217-237.
  28. Rabitz, F. (2025). A theory of international technology regulation. Review of International Studies, 1-18.
  29. Rühlig, T. (2023). Chinese influence through technical standardization power. Journal of Contemporary China, 32(139), 54-72.
  30. Russel, D. R., & Berger, B. H. (2021). Stacking the deck: China's influence in international technology standards setting. Asia Society Policy Institute.
  31. Schott, L., & Schaefer, K. J. (2023). Acceptance of Chinese latecomers' technological contributions in international ICT standardization—The role of origin, experience and collaboration. Research Policy, 52(1), 104656.
  32. Secretariat of the Convention on Biological Diversity. 2022. Synthetic Biology. CBD Technical Series No. 100. Montreal, 196 pages.
  33. Sun, T., Song, J., Wang, M., Zhao, C., & Zhang, W. (2022). Challenges and recent progress in the governance of biosecurity risks in the era of synthetic biology. Journal of Biosafety and Biosecurity, 4(1), 59-67.
  34. Tallberg, J., Erman, E., Furendal, M., Geith, J., Klamberg, M., & Lundgren, M. (2023). The global governance of artificial intelligence: Next steps for empirical and normative research. International Studies Review, 25(3), viad040.
  35. Trump, B. D. (2017). Synthetic biology regulation and governance: Lessons from TAPIC for the United States, European Union, and Singapore. Health Policy, 121(11), 1139-1146.
  36. Wang, C., & Zhou, W. (2023). A political anatomy of China’s compliance in WTO disputes. Journal of Contemporary China, 32(143), 811-827.
  37. Wang, F., & Zhang, W. (2019). Synthetic biology: recent progress, biosafety and biosecurity concerns, and possible solutions. Journal of Biosafety and Biosecurity, 1(1), 22-30.
  38. Wang, L., Song, J., & Zhang, W. (2021). Tianjin Biosecurity Guidelines for codes of conduct for scientists: Promoting responsible sciences and strengthening biosecurity governance. Journal of Biosafety and Biosecurity, 3(2), 82-83.
  39. World Economic Forum. Global Technology Governance Report 2021, https://www.weforum.org/publications/global-technology-governance-report-2021/
  40. Xue, L. (2023). International Rule-making in the Field of Emerging Technologies: Path Selection and Participation Strategies. Frontiers, (19), 15-21. (薛澜.(2023).新兴科技领域国际规则制定:路径选择与参与策略. 人民论坛·学术前沿, (19), 15-21.)
  41. Yang, J. (2022). Understanding China’s changing engagement in global climate governance: a struggle for identity. Asia Europe Journal, 20(4), 357-376.

Xu, X. China’s Role in the Global Governance of Synthetic Biology: Between Revisionism and the Status Quo. Journal of International Economy and Global Governance 2025, 2 (6), 37-51. https://doi.org/10.12414/jiegg.250841.

Subscribe Your Manuscript